Atrium Therapeutics Inc (RNA)

CapEx to Revenue

1.20%

Quarterly · Period ending:

RNA logo

RNA CapEx to Revenue

Latest reported1.20%
RNA Quarterly CapEx/Revenue (0.00% → 1.20%)
High-resolution chart · PNG

RNA capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Atrium Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
1.1984%
10.685%
102.3283%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.